Follow
James A.L. Brown
James A.L. Brown
Associate Professor in Cancer and Cell Biology, University of Limerick. ORCID:0000-0002-3155-0334
Verified email at ul.ie - Homepage
Title
Cited by
Cited by
Year
Effects of Age on the Detection and Management of Breast Cancer
A McGuire, JAL Brown, C Malone, R McLaughlin, MJ Kerin
Cancers 7 (2), 908-929, 2015
3842015
Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring.
A McGuire, JA Brown, MJ Kerin
Cancer Metastasis Rev. 34, 145–155, 2015
3482015
Rational design and validation of a Tip60 histone acetyltransferase inhibitor
C Gao, E Bourke, M Scobie, MA Famme, T Koolmeister, T Helleday, ...
Scientific reports 4, 5372, 2014
1242014
Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer
P McAnena, JAL Brown, K Michael J.
Cancers 9 (1), 5, 2017
992017
Multiple Facets of the DNA Damage Response Contribute to the Radioresistance of Mouse Mesenchymal Stromal Cell Lines
T Sugrue, JAL Brown, NF Lowndes, R Ceredig
STEM CELLS 31 (1), 137-145, 2013
822013
Circulating microRNAs miR-331 and miR-195 differentiate local luminal A from metastatic breast cancer
P McAnena, K Tanriverdi, C Curran, K Gilligan, JE Freedman, JAL Brown, ...
BMC Cancer 19, 2019
752019
A novel role for hSMG-1 in stress granule formation
JAL Brown, TL Roberts, R Richards, R Woods, G Birrell, YC Lim, S Ohno, ...
Molecular and cellular biology 31 (22), 4417-4429, 2011
642011
Smg1 haploinsufficiency predisposes to tumor formation and inflammation
TL Roberts, U Ho, J Luff, CS Lee, SH Apte, KPA MacDonald, LJ Raggat, ...
Proceedings of the National Academy of Sciences 110 (4), E285-E294, 2013
632013
Targeting cancer using KAT inhibitors to mimic lethal knockouts
JAL Brown, E Bourke, LA Eriksson, MJ Kerin
Biochemical Society Transactions 44 (4), 979-986, 2016
592016
DNA damage induces Chk1-dependent threonine-160 phosphorylation and activation of Cdk2
E Bourke, JAL Brown, S Takeda, H Hochegger, CG Morrison
Oncogene 29 (4), 616-624, 2009
562009
Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options
PF McAnena, A McGuire, A Ramli, C Curran, C Malone, R McLaughlin, ...
BMC cancer 18 (1), 203, 2018
542018
Exploring circulating micro‐RNA in the neoadjuvant treatment of breast cancer
MC Casey, KJ Sweeney, JAL Brown, MJ Kerin
International journal of cancer 139 (1), 12-22, 2016
522016
MCPH1/BRIT1 limits ionizing radiation-induced centrosome amplification
JAL Brown, E Bourke, C Liptrot, P Dockery, CG Morrison
Oncogene 29 (40), 5537-5544, 2010
442010
Screening of exosomal microRNAs from colorectal cancer cells
C Clancy, S Khan, CL Glynn, E Holian, P Dockery, P Lalor, JAL Brown, ...
Cancer Biomarkers 17 (4), 427-435, 2016
402016
Large expert-curated database for benchmarking document similarity in biomedical literature search
P Brown, R Consortium, Y Zhou
DATABASE 2019 (baz085), 1-67, 2019
332019
Quantifying Argonaute 2 (Ago2) expression to stratify breast cancer
MC Casey, A Prakash, E Holian, A McGuire, O Kalinina, A Shalaby, ...
BMC Cancer 19 (1), 712, 2019
322019
Prospective assessment of microRNA as markers of response to neoadjuvant chemotherapy in breast cancer.
A McGuire, MC Casey, R Waldron, H Heneghan, O Kaliningrad, E Holian, ...
Cancers 12 (7 10.3390/cancers12071820), 1820, 2020
312020
Advances in Precision Medicine: Tailoring Individualized Therapies.
KB Matchett, N Lynam-Lennon, RW Watson, JAL Brown
Cancers (Basel). 9 (11), E146, 2017
292017
Evaluating the effectiveness of a practical inquiry-based learning bioinformatics module on undergraduate student engagement and applied skills
JAL Brown
Biochemistry and Molecular Biology Education 44 (3), 304–313, 2016
282016
Quantifying Tip60 protein level stratifies breast cancer.
A McGuire, MC Casey, A Shalaby, E Holian, O Kalinina, C Curran, ...
Scientific Reports. 9 (1), 3819, 2019
25*2019
The system can't perform the operation now. Try again later.
Articles 1–20